NASDAQ
Advanced Biomedical Technologies, Inc. (ABMT) has a free cash flow growth of 13.39% as of Friday, May 29, 2026. This represents a 202.76% increase compared to its 12-month average of -13.03%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.